Home › Funds › Kalehua Capital Management LLC › IKT

Kalehua Capital Management LLC position in IKT

INHIBIKASE THERAPEUTICS INC · Health Care

Kalehua Capital Management LLC reported holding 3,821,890 shares of IKT (INHIBIKASE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.9M, representing 5.93% of its reported portfolio and ranking #7 among its reported holdings. Kalehua Capital Management LLC has disclosed IKT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)3.82M sh
Reported value held$7.85M
Portfolio Weight5.93%
First reportedQ4 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Kalehua Capital Management LLC's IKT position evolved

Kalehua Capital Management LLC first disclosed a stake in IKT in Q4 2025 at 1,750,000 shares (US$3.6M). The position peaked in Q3 2026 at 3,821,890 shares, worth US$7.9M. Across 4 filings, Kalehua Capital Management LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 3,821,890 shares valued at US$7.9M. Notable position changes include a 118% increase in Q1 2026 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.75M $3.59M New
Q1 2026 3.82M $6.42M Add
Q2 2026 3.82M $7.76M Hold
Q3 2026 3.82M $7.85M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IKT and 13F data

IKT (INHIBIKASE THERAPEUTICS INC) is a Health Care company. 67 other funds we track also report a position in IKT — the largest reported positions include Sands Capital Alternatives, LLC (US$26.8M), Soleus Capital Management, L.P. (US$22.1M), Trails Edge Capital Partners, LP (US$18.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IKT

All IKT fund holders →

FAQ

How long has Kalehua Capital Management LLC held IKT?

Kalehua Capital Management LLC has disclosed IKT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Kalehua Capital Management LLC's current position in IKT?

As of Q3 2026, Kalehua Capital Management LLC holds 3.82M shares of IKT (INHIBIKASE THERAPEUTICS INC), valued at $7.85M, representing 5.93% of its reported portfolio and ranking #7.

Has Kalehua Capital Management LLC been buying or selling IKT?

In the latest 13F filing (Q3 2026), Kalehua Capital Management LLC held unchanged its position in IKT. The position peaked in Q3 2026 at 3.82M shares.

Which other funds hold IKT?

Other major institutional holders of IKT include Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., Trails Edge Capital Partners, LP, among 67 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.